As the DEA reopened the ECPS interim final rule for comments, DrFirst has suggested a number of improvements to ePrescribing of controlled substances that embrace today's technology while still maintaining the privacy and security needs of ECPS.  To learn more about their suggestions, we sat down with Cam Deemer, President of DrFirst to talk about the following ECPS suggestions:  

* Incorporate current industry guidelines and standards * Allow two authentication factors on one device 

* Adopt innovative alternatives to two-factor authentication 

* Clarify identity-proofing requirements 

* Update requirements for biometrics  

Learn more about DrFirst: https://drfirst.com/